Transcription of An algorithm for managing warfarin resistance - ccjm
{{id}} {{{paragraph}}}
REVIEW. CME EDUCATIONAL OBJECTIVE: Readers will recognize and appropriately manage warfarin resistance in patients CREDIT who need higher-than-expected doses of this drug Olusegun Osinbowale, MD, MBA, RPVI Monzr Al Malki, MD Andrew Schade, MD, PhD John R. Bartholomew, MD. Department of Cardiology, Section of Noninvasive Biotherapeutics Department Labora- Division of Pathology and Laboratory Department of Cardiovascular Cardiology, Ochsner Clinic Foundation, New Orleans, LA tory, Division of Surgical Research, Medicine, Department of Clinical Medicine, Head, Section of Vascular Boston University School of Medicine, Pathology, Cleveland Clinic Medicine, Cleveland Clinic Roger Williams Medical Center, Providence, RI. An algorithm for managing warfarin resistance Abstract Some patients need higher-than-expected doses of W arfarin (coumadin) differs from most other drugs in that the dosage required to achieve a desired therapeutic effect varies warfarin (Coumadin) to get their international normal- greatly among individuals.
warfarin (Coumadin) to get their international normal-ized ratio (INR) into the therapeutic range. The cause of warfarin resistance can be either acquired (eg, poor compliance, drug interactions, dietary interactions) or hereditary, but the genetic mechanisms of warfarin resistance are not well understood. This review offers an
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}